In order to evaluate the prognosis value of PIK3CA mutation in CRC patients, 1946 patients with available follow-up information were collected for survival analysis (clinicopathologic characteristics were shown in Table S4). This evidence concerns the gene PIK3CA and colorectal carcinoma.